NCT06106451

Brief Summary

In this study, the investigators will evaluate the feasibility and potential efficacy of programs to improve functional outcomes after minimally-invasive transcatheter aortic valve replacement (TAVR). The investigators will examine the potential efficacy of (a) a motivation interviewing program, and (b) a home-based physical activity + motivational interviewing program, compared to (c) usual care + enhanced education in patients post-TAVR procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 30, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 29, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2025

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2025

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

1.7 years

First QC Date

October 24, 2023

Last Update Submit

February 25, 2026

Conditions

Keywords

aortic valve replacementminimally invasive transcatheter aortic valve replacementTAVR

Outcome Measures

Primary Outcomes (2)

  • Number of motivational interviewing sessions attended

    This outcome will measure the number of motivational interviewing sessions in which the patient participates. Motivational Interviewing Arm Outcome.

    Approximately 20 weeks after the day of the TAVR procedure

  • Number of home-based activity sessions attended

    This outcome will measure the number of home-based activity sessions the patient logs. Home-based Activity Arm

    Approximately 20 weeks after the day of the TAVR procedure

Secondary Outcomes (13)

  • Number of Cardiac Rehabilitation Sessions Attended

    Approximately 20 weeks after the day of the TAVR procedure

  • Number of Barriers to Attending Cardiac Rehabilitation Sessions

    Approximately 20 weeks after the day of the TAVR procedure

  • Health Status as assessed by the EuroQol 5 Dimension 5 Level (EQ-5D-5L)

    Approximately 20 weeks after the day of the TAVR procedure

  • Health Status as assessed by the The Kansas City Cardiomyopathy Questionnaire (KCCQ)

    20 weeks after the day of the TAVR procedure

  • Disability as assessed by the World Health Organization Disability Assessment Schedule (WHO-DAS 2.0)

    Approximately 20 weeks after the day of the TAVR procedure

  • +8 more secondary outcomes

Study Arms (3)

Standard of Care plus Enhanced Patient Education

ACTIVE COMPARATOR

Each participant in this arm will receive enhanced patient education. The research staff will discuss the benefits of cardiac rehabilitation and provide a pamphlet describing the benefits discussed. The research staff will also call the patient four times throughout their participation in the study to encourage physical activity. The enhanced patient education program will begin approximately 2 weeks after the TAVR procedure.

Behavioral: Standard of Care plus Enhanced Patient Education

Motivational Interviewing Intervention

ACTIVE COMPARATOR

Each participant in this arm will have a motivational interviewing program created by a psychologist. The motivational interviewing program will be tailored to the individual participant. The goal of the motivational interviewing program is improved adherence to standard of care cardiac rehabilitation. The motivational interviewing program will begin approximately 2 weeks after the TAVR procedure.

Behavioral: Motivational Interviewing Intervention

Home-Based Activity Program plus Motivational Interviewing Intervention

ACTIVE COMPARATOR

Each participant in this arm will be evaluated by a physical therapist and psychologist. The physical therapist will use the evaluation to create an individually tailored home-based activity program plan. This home-based activity program will be implemented at the 1-month post-operative cardiology clinic appointment. The psychologist will use the evaluation to create an individually tailored motivational interviewing program. The motivational interviewing program will begin approximately 2 weeks after the TAVR procedure.

Behavioral: Home-Based Activity Program plus Motivational Interviewing Intervention

Interventions

Patients in this arm will receive a pamphlet explaining the benefits of cardiac rehabilitation. This pamphlet will be given in addition to standard of care patient education. The research team will also call the patient at four specified time points to provide additional information.

Standard of Care plus Enhanced Patient Education

Patients in this arm of the study will participate in a tailor-made motivational interviewing program. These motivational interviewing sessions will focus on enhancing communication with patients. Each motivational interviewing session will be approximately one hour long. There will be a total of 4-6 motivational interviewing sessions.

Motivational Interviewing Intervention

Patients in this arm will be evaluated on postoperative day 1 by a physical therapist on the study team. After the evaluation, the physical therapist will use the information from the evaluation to make a tailored home-based physical activity program for the patient. The patient will begin the home-based physical activity program on the day of their 1-month post-operative cardiology clinic appointment. In addition to the home-based activity program, patients will participate in a tailor-made motivational interviewing program. These motivational interviewing sessions will focus on enhancing communication with patients. Each motivational interviewing session will be approximately one hour long. There will be a total of 4-6 motivational interviewing sessions.

Home-Based Activity Program plus Motivational Interviewing Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Undergoing TAVR procedure
  • ≥65 years old
  • Ambulatory at baseline without assistance
  • Approval of the interventional cardiologist that the patient is an appropriate candidate
  • Can access telephone or teleconference

You may not qualify if:

  • Impaired cognition that would limit participation in study activities
  • Medical comorbidities that substantially limit exercise
  • Major cardiac comorbidities, including ejection fraction\<35%, history of cardiac arrest, complex dysrhythmias at rest, clinically-significant incomplete revascularization, implanted cardiac defibrillator.
  • Physical characteristics that substantially limit exercise
  • High fall risk (Johns Hopkins Fall Risk Assessment Tool indicating high risk)
  • Non-English Speaking
  • Vigorous exercise at least 2 times/week for \>30 minutes
  • Any other physician judgement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Johns Hopkins University

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

Aortic Valve Disease

Interventions

Standard of CareMotivational Interviewing

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationDirective CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Charles Brown, MD

    Johns Hopkins Uiversity

    STUDY DIRECTOR
  • Giancarlo Suffredini, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be masked.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Patients will be randomized to one of the 3 arms of the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2023

First Posted

October 30, 2023

Study Start

January 29, 2024

Primary Completion

October 14, 2025

Study Completion

November 3, 2025

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

No IPD is anticipated to be shared

Locations